ArticleThe oncologist2023

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.

Mirella Nardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.